Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). https://creativecommons.org/licenses/by-nc/4.0/. Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The book in its entirety is subject to copyright by the publisher. The reproduction, modification, replication and display of the book in its entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Cerebral ischemia is one of the most common causes of dementia, which develops in more than half of patients after an ischemic episode. The main mechanism is thought to be pathological changes in the hippocampus, especially in the CA1 area, underlying episodic memory impairment, which is the earliest and most important clinical symptom of post-ischemic dementia. The 13 chapters of this book present a new picture of ischemic brain disease, synthesizing the latest data on disease mechanisms, care for patients with this disease, and potential therapeutic targets. The authors present the characteristics of cerebral ischemia from pregnancy and childhood through adolescence to adulthood. The first two chapters provide a snapshot of the anatomy of the cerebral cortex and the hippocampus, the most affected brain structures after cerebral ischemia. This is followed by nine chapters that present a comprehensive view of the pathological mechanisms of cerebral ischemia, and how a deep understanding of these pathomechanisms hold the key for the discovery and development of novel therapies to help patients affected by cerebral ischemia. Chapter 12 shares real-life experience and challenges of rehabilitating patients into the community after cerebral ischemia, and chapter 13 analyzes the social risk variations, including gender inequality, in the reintegration of post-ischemic stroke patients. Although primarily aimed at scientists and clinicians, the contents of the book will be of interest to all those who are interested in cerebral ischemia, including patients and their caregivers.
Contents
- Foreword
- Preface
- List of Contributors
- 1. The Anatomy of the Cerebral CortexPradip Chauhan, Ashish Rathawa, Kinjal Jethwa, and Simmi Mehra.
- 2. The Anatomy of the HippocampusPradip Chauhan, Kinjal Jethwa, Ashish Rathawa, Girish Chauhan, and Simmi Mehra.
- INTRODUCTION
- INDUSIUM GRISEUM AND LONGITUDINAL STRIAE
- DENTATE GYRUS
- HIPPOCAMPUS
- MICROSCOPIC STRUCTURE
- ORGANIZATION OF PYRAMIDAL CELLS IN HIPPOCAMPUS
- CONNECTIONS OF HIPPOCAMPUS
- FORNIX
- HABENULAR NUCLEI
- MAMMILO-TEGMENTAL TRACT
- MAMMILO-THALAMIC TRACT
- HIPPOCAMPAL FORMATION AND MEMORY
- BLOOD SUPPLY AND DRAINAGE OF HIPPOCAMPUS
- CONCLUSION
- REFERENCES
- 3. Genes Associated with Alzheimer’s Disease in Post-Ischemic Brain NeurodegenerationRyszard Pluta and Marzena Ułamek-Kozioł.
- 4. Hypoxic-Ischemic Brain Injury after Perinatal Asphyxia as a Possible Factor in the Pathology of Alzheimer’s DiseaseAgata Tarkowska.
- 5. Ischemic Brain Injury in HyperhomocysteinemiaJan Lehotsky, Maria Kovalska, Eva Baranovicova, Petra Hnilicova, Dagmar Kalenska, and Peter Kaplan.
- 6. Exosomes in Post-Ischemic BrainRyszard Pluta and Mirosław Jabłoński.
- 7. Neuroinflammation in Post-Ischemic BrainKatarina Živančević, Darko Lović, Pavle R. Andjus, and Lidija Radenović.
- 8. Neurovascular Reactivity in Tissue Scarring Following Cerebral IschemiaDaniel Manrique-Castano and Ayman ElAli.
- 9. The Role of Cathepsin B in Ischemia-Reperfusion Injury After StrokeBhakta Prasad Gaire, Lalita Subedi, Hironori Teramoto, and Bingren Hu.
- 10. The Role of Curcumin in Post-Ischemic BrainMarta Rusek and Stanisław J. Czuczwar.
- 11. Treating Cerebral Ischemia: Novel Therapeutic Strategies from Experimental Stroke ResearchXuan Zheng, Matteo Haupt, Mathias Bähr, Lars Tatenhorst, and Thorsten R. Doeppner.
- 12. Community-Based Rehabilitation After Brain Infarction in Japan: From the Acute Phase to HomeShinichiro Maeshima and Aiko Osawa.
- INTRODUCTION
- PATHOLOGY OF CEREBRAL INFARCTION AND REHABILITATION
- REHABILITATION IN THE ACUTE PHASE
- REHABILITATION IN THE RECOVERY PHASE
- REHABILITATION IN THE MAINTENANCE PHASE
- WALKING AIDS
- FAMILY-PARTICIPATORY VOLUNTARY TRAINING AND GUIDANCE FOR FAMILY MEMBERS AND CAREGIVERS
- TELEMEDICINE: TELESTROKE AND TELEREHABILITATION
- REHABILITATION HOSPITALS AND FACILITIES AND LEGAL IMPROVEMENT
- CONCLUSION
- REFERENCES
- 13. Understanding Social Risk Variation Across Reintegration of Post-Ischemic Stroke PatientsKatryna Cisek, Thi Nguyet Que Nguyen, Alejandro Garcia-Rudolph, Joan Saurí, and John D. Kelleher.
Professor Ryszard Pluta, MD, PhD, is the head of the Laboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland. He has held positions at the National Institutes of Health, Bethesda, USA, at the Institute for Basic Research in Developmental Disabilities, Staten Island, USA, and at the Max-Planck Institute for Neurological Research in Cologne, Germany. Professor Pluta was awarded by the Polish Association of Neuropathologists, President of Polish Academy of Sciences, Medical Secretary of Polish Academy of Sciences, Batory’s Foundation in Warsaw, Poland, International Brain Research Organization in Paris, France, and Alzheimer’s Association Chicago, USA. In 2017, Professor Pluta was awarded the Maria Curie-Skłodowska statuette. In New York in 1994 he was the first to propose the ischemic etiology of Alzheimer’s disease, followed by publications in which he presented proteomic and genomic alterations in the ischemic brain that are identical to those in Alzheimer’s disease. In 1998, he was the first to present autoimmunization as a new therapy for Alzheimer’s disease. Professor Pluta has published more than 250 peer-reviewed scientific articles and his current research focuses on developing ischemic model of Alzheimer’s disease. He is listed among the top 2% outstanding scientists in the world.
Cerebral Ischemia
ISBN: 978-0-6450017-9-2
DOI: https://doi.org/10.36255/exonpublications.cerebralischemia.2021
Edited by
Ryszard Pluta, MD, PhD, Laboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
Published by
Exon Publications, Brisbane, Australia
Copyright© 2021 Exon Publications
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). https://creativecommons.org/licenses/by-nc/4.0/. Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The book in its entirety is subject to copyright by the publisher. The reproduction, modification, replication and display of the book in its entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.
Notice to the user
The views and opinions expressed in this book are believed to be accurate at the time of publication. The publisher, editors or authors cannot be held responsible or liable for any errors, omissions or consequences arising from the use of the information contained in this book. The publisher makes no warranty, implicit or explicit, with respect to the contents of this book, or its use.
First Published in November 2021
Printed in Australia
- NLM CatalogRelated NLM Catalog Entries
- Post-ischemic salubrinal treatment results in a neuroprotective role in global cerebral ischemia.[J Neurochem. 2016]Post-ischemic salubrinal treatment results in a neuroprotective role in global cerebral ischemia.Anuncibay-Soto B, Pérez-Rodríguez D, Santos-Galdiano M, Font E, Regueiro-Purriños M, Fernández-López A. J Neurochem. 2016 Jul; 138(2):295-306. Epub 2016 May 16.
- Review Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease.[Int J Mol Sci. 2021]Review Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease.Pluta R, Ouyang L, Januszewski S, Li Y, Czuczwar SJ. Int J Mol Sci. 2021 Feb 28; 22(5). Epub 2021 Feb 28.
- Review Alzheimer's Disease Connected Genes in the Post-Ischemic Hippocampus and Temporal Cortex.[Genes (Basel). 2022]Review Alzheimer's Disease Connected Genes in the Post-Ischemic Hippocampus and Temporal Cortex.Pluta R. Genes (Basel). 2022 Jun 14; 13(6). Epub 2022 Jun 14.
- [Neural pathway participates in protection of limb ischemic preconditioning against brain injuries induced by ischemia/reperfusion in rats].[Zhongguo Ying Yong Sheng Li Xu...][Neural pathway participates in protection of limb ischemic preconditioning against brain injuries induced by ischemia/reperfusion in rats].Zhao HG, Li WB, Sun XC, Li QJ, Ai J, Li DL. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2007 Feb; 23(1):19-23.
- Review Molecular Hydrogen Neuroprotection in Post-Ischemic Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Underlying Mechanisms and Potential for Clinical Implementation-Fantasy or Reality?[Int J Mol Sci. 2022]Review Molecular Hydrogen Neuroprotection in Post-Ischemic Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Underlying Mechanisms and Potential for Clinical Implementation-Fantasy or Reality?Pluta R, Januszewski S, Czuczwar SJ. Int J Mol Sci. 2022 Jun 13; 23(12). Epub 2022 Jun 13.
- Cerebral IschemiaCerebral Ischemia
- Homo sapiens mRNA for ATL-derived PMA-responsive peptide, complete cdsHomo sapiens mRNA for ATL-derived PMA-responsive peptide, complete cdsgi|219475|dbj|D90070.1|HUMAPRNucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...